Key result
~20% of early-stage breast cancer patients report persistent worry at 5 years, especially younger, lower-income groups.
Why the study?
The long-term experience of worry among patients with early-stage breast cancer requires better understanding and validated instruments for efficient measurement.
Population
2502 women with early-stage breast cancer diagnosed in 2013-15 reported to Georgia and Los Angeles SEER registries
Design
Longitudinal population-based cohort study
Authors
Loading...
May support screening for recurrence worry in long-term survivors; leaves open need for intervention trials in younger, minority, and lower-income subgroups.
More than 20% of patients with early-stage breast cancer experience significant worry about recurrence extending well beyond 5 years after diagnosis.
Linos et al. (2026) studied this question. Over 20% of early-stage breast cancer patients report worry impacting upset feelings up to 5+ years post-diagnosis, with higher scores in younger, Asian/Latina, lower income groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: